Literature DB >> 11033258

Acute changes in cochlear potentials due to cisplatin.

N Tsukasaki1, C A Whitworth, L P Rybak.   

Abstract

The purpose of this study was to investigate how the hair cells and stria vascularis are affected at the onset of cisplatin ototoxicity. The effects on the endocochlear potential (EP) and the cochlear microphonics (CM) were observed simultaneously in two groups of adult chinchillas receiving as follows: (1) 5 microl of cisplatin (1 mg/ml) in normal saline, and (2) 5 microl of normal saline on the round window. The EP and the CM were recorded for 12-14 h after cisplatin application, and morphological changes were assessed using scanning electron microscopy. Both the EP and the CM amplitude demonstrated a profound reduction, and a very strong correlation was observed between these two values during this time period. Although the reduction of the EP and the CM was observed by 12-14 h, only very slight degeneration of outer hair cells was seen at that time. These data suggested that a reduction of the EP which was caused by the alteration of the stria vascularis might be primarily responsible for very early changes in cochlear function after topical cisplatin application, while later changes were the direct result of hair cell damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11033258     DOI: 10.1016/s0378-5955(00)00182-9

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  12 in total

1.  [The "Muenster classification" of high frequency hearing loss following cisplatin chemotherapy].

Authors:  C-M Schmidt; E Bartholomäus; D Deuster; A Heinecke; A G Dinnesen
Journal:  HNO       Date:  2007-04       Impact factor: 1.284

2.  Distortion-product otoacoustic emission test performance for ototoxicity monitoring.

Authors:  Kelly M Reavis; Garnett McMillan; Donald Austin; Frederick Gallun; Stephen A Fausti; Jane S Gordon; Wendy J Helt; Dawn Konrad-Martin
Journal:  Ear Hear       Date:  2011-02       Impact factor: 3.570

3.  The Protective Effect of Chrysin Against Cisplatin İnduced Ototoxicity in Rats.

Authors:  Mehmet Kelles; Mehmet Tan; M Tayyar Kalcioglu; Yuksel Toplu; Nazire Bulam
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-11-28

4.  The effect of resveratrol on the prevention of cisplatin ototoxicity.

Authors:  T Erdem; Tuba Bayindir; A Filiz; M Iraz; E Selimoglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-21       Impact factor: 2.503

Review 5.  Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

Authors:  Jochen Schacht; Andra E Talaska; Leonard P Rybak
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

6.  Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy.

Authors:  Nesrine Benkafadar; Julien Menardo; Jérôme Bourien; Régis Nouvian; Florence François; Didier Decaudin; Domenico Maiorano; Jean-Luc Puel; Jing Wang
Journal:  EMBO Mol Med       Date:  2017-01       Impact factor: 12.137

7.  Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.

Authors:  Vikrant Borse; Raheem F H Al Aameri; Kelly Sheehan; Sandeep Sheth; Tejbeer Kaur; Debashree Mukherjea; Srinivasan Tupal; Michelle Lowy; Sumana Ghosh; Asmita Dhukhwa; Puspanjali Bhatta; Leonard P Rybak; Vickram Ramkumar
Journal:  Cell Death Dis       Date:  2017-07-13       Impact factor: 8.469

8.  Sirtuin 1 and Autophagy Attenuate Cisplatin-Induced Hair Cell Death in the Mouse Cochlea and Zebrafish Lateral Line.

Authors:  Jiaqi Pang; Hao Xiong; Ting Zhan; Gui Cheng; Haiying Jia; Yongyi Ye; Zhongwu Su; Hongyu Chen; Hanqing Lin; Lan Lai; Yongkang Ou; Yaodong Xu; Suijun Chen; Qiuhong Huang; Maojin Liang; Yuexin Cai; Xueyuan Zhang; Xiaoding Xu; Yiqing Zheng; Haidi Yang
Journal:  Front Cell Neurosci       Date:  2019-01-14       Impact factor: 5.505

9.  The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss.

Authors:  Sumana Ghosh; Sandeep Sheth; Kelly Sheehan; Debashree Mukherjea; Asmita Dhukhwa; Vikrant Borse; Leonard P Rybak; Vickram Ramkumar
Journal:  Front Cell Neurosci       Date:  2018-08-21       Impact factor: 5.505

Review 10.  Preferential Cochleotoxicity of Cisplatin.

Authors:  Pattarawadee Prayuenyong; David M Baguley; Corné J Kros; Peter S Steyger
Journal:  Front Neurosci       Date:  2021-07-26       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.